drugset
Drugs / 2018-19 quadrivalent inactivated influenza vaccine
last change Jun 2025 re-read 3 minutes ago

2018-19 quadrivalent inactivated influenza vaccine

Vaccine

Developed for
influenza
Investigated by
British Columbia Centre for Disease Control · Institut National en Santé Publique du Québec · McGill University Health Centre/Research Institute of the McGill University Health Centre · Vaccine Evaluation Center, Canada

Trials 1

today NCT03753347 · Ph 4
20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03753347 Dec 2018 → Apr 2019 overdue influenza British Columbia Centre for Disease Control Active not recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 2018-19 quadrivalent inactivated influenza vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT03753347 ↗
Modality Vaccine “quadrivalent inactivated influenza vaccine” NCT03753347 ↗